, Tracking Stock Market Picks
Enter Symbol:
Amarin Corporation Plc (AMRN) [hlAlert]

Neutral AMRN

Amarin Corporation Plc (AMRN) rated Neutral with price target $1.75 by MKM Partners

Posted on: Monday,  Feb 24, 2014  11:25 AM ET by MKM Partners

MKM Partners rated Neutral Amarin Corporation Plc (NASDAQ: AMRN) on 02/24/2014. Previously MKM Partners rated Buy Amarin Corporation Plc (NASDAQ: AMRN) on
11/08/2013., when the stock price was $1.62. Since then, Amarin Corporation Plc has gained 40.12% as of 01/16/2014's recent price of $2.27.
If you would have followed the previous MKM Partners's recommendation on AMRN, you would have gained 40.12% of your investment in 69 days.

Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical company with a focus on cardiovascular disease. Amarin has a range of clinical and preclinical stage compounds to treat central nervous system (CNS) disorders, including Huntington?s disease, myasthenia gravis and Parkinson?s disease. Its cardiovascular programs and non-core CNS programs include AMR101, EN101, Sublingual Apomorphine and AMR 103. The Company's subsidiaries include Amarin Neuroscience Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma Inc, Amarin Finance Limited and Ester Neurosciences Limited.

MKM Partners LLC is an institutional equity trading and research firm. MKM Partners has extensive experience in the agency execution of U.S. and international equity orders. We provide clients with timely and unbiased economic, technical, and fundamental research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/24/2014 11:25 AM Hold
1.92 1.75
as of 10/17/2014
1 Week   
1 Month   
3 Months   
1 YTD up  15.22 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/16/2014 11:25 AM Hold
2.27 2.50
11/8/2013 11:25 AM Buy
1.62 2.50
10/17/2013 11:25 AM Buy
2.05 5.00
7/12/2011 11:25 AM Buy
14.20 23.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy